50 studies found for:    Open Studies | "Spondylitis, Ankylosing"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Spondylitis, Ankylosing"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
2 Recruiting Progression of Spinal Fusion in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
3 Unknown  Clinical and Radiographic Correlation of Ultrasound MASEI Index in Patients With Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
4 Recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Condition: Spondylitis, Ankylosing
Interventions: Drug: Secukinumab;   Drug: Placebo secukinumab
5 Recruiting A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
Condition: Spondylitis, Ankylosing
Interventions: Drug: Part I - etoricoxib 60 mg;   Drug: Part I - etoricoxib 90 mg;   Drug: Part I- naproxen 1000 mg;   Drug: Part I - Placebo to naproxen 500 mg;   Drug: Part II- etoricoxib 60 mg;   Drug: Part II- etoricoxib 90 mg;   Drug: Part II- naproxen 1000 mg;   Drug: Part I - Placebo to etoricoxib 60 mg;   Drug: Part I - Placebo to etoricoxib 90 mg;   Drug: Part II- Placebo to etoricoxib 60 mg;   Drug: Part II - Placebo to etoricoxib 90 mg;   Drug: Part II- Placebo to naproxen 500 mg
6 Recruiting BI 655066 Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
Condition: Spondylitis, Ankylosing
Interventions: Drug: Placebo;   Drug: BI 655066
7 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
8 Unknown  Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: abatacept
9 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
10 Recruiting Biologic Rheumatology Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
11 Recruiting Extension in AS: Sustainability of Benefits, Safety and Tolerability
Condition: Spondylitis, Ankylosing
Intervention: Biological: Secukinumab
12 Recruiting Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Condition: Ankylosing Spondylitis
Intervention:
13 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
14 Unknown  Prednisolone in Active Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Drug: prednisolone
15 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo
16 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
17 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
18 Recruiting Efficacy at 16 Weeks and Long Term Efficacy, Safety and Tolerability up to 5 Years of Secukinumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: AIN457;   Biological: Placebo
19 Recruiting Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
Condition: Ankylosing Spondylitis
Interventions: Drug: Adalimumab;   Drug: Methotrexate
20 Recruiting Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
Condition: Ankylosing Spondylitis
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years